BDBM309329 (2R,3aS,4R,9bS)-12-(cyclopropylmethyl)- N-(2-guanidinoethyl)-3a,8-dihydroxy- 1,2,3,3a,4,5-hexahydro-4,9b-(epimino- ethano)cyclopenta[a]naphthalene-2- carboxamide::US9656962, Compound 6

SMILES NC(=N)NCCNC(=O)[C@H]1C[C@@]2(O)[C@H]3Cc4ccc(O)cc4[C@]2(C1)CCN3CC1CC1

InChI Key InChIKey=ZLARBRFVWKMWNZ-BGACZQCLSA-N

Data  4 KI  2 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 6 hits for monomerid = 309329   

TargetKappa-type opioid receptor(Homo sapiens (Human))
Purdue Pharma

US Patent
LigandPNGBDBM309329((2R,3aS,4R,9bS)-12-(cyclopropylmethyl)- N-(2-guani...)
Affinity DataKi:  0.0980nMAssay Description:Radioligand binding assays (screening and dose-displacement) use 0.1 nM [3H]-nociceptin (Perkin Elmer, Shelton, Conn.; 87.7 Ci/mmole) with 12 μg...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
Purdue Pharma

US Patent
LigandPNGBDBM309329((2R,3aS,4R,9bS)-12-(cyclopropylmethyl)- N-(2-guani...)
Affinity DataKi:  19.7nMAssay Description:δ-Opioid Receptor Binding Assay Procedures: δ-Opioid Receptor Binding Assay Procedures were conducted as follows. Radioligand dose-displace...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDelta-type opioid receptor(Homo sapiens (Human))
Purdue Pharma

US Patent
LigandPNGBDBM309329((2R,3aS,4R,9bS)-12-(cyclopropylmethyl)- N-(2-guani...)
Affinity DataKi:  7.71E+3nMAssay Description: Radioligand dose-displacement binding assays for μ-opioid receptors used 0.3 nM [3H]-diprenorphine (Perkin Elmer, Shelton, Conn.), with 5 mg me...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNociceptin receptor(Homo sapiens (Human))
Purdue Pharma

US Patent
LigandPNGBDBM309329((2R,3aS,4R,9bS)-12-(cyclopropylmethyl)- N-(2-guani...)
Affinity DataKi:  1.03E+4nMAssay Description:κ-Opioid Receptor Binding Assay Procedures: Membranes from HEK-293 cells, CHO cells or U-2 OS cells expressing the recombinant human kappa opioi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetKappa-type opioid receptor(Homo sapiens (Human))
Purdue Pharma

US Patent
LigandPNGBDBM309329((2R,3aS,4R,9bS)-12-(cyclopropylmethyl)- N-(2-guani...)
Affinity DataEC50:  0.860nMAssay Description:Radioligand binding assays (screening and dose-displacement) use 0.1 nM [3H]-nociceptin (Perkin Elmer, Shelton, Conn.; 87.7 Ci/mmole) with 12 μg...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
Purdue Pharma

US Patent
LigandPNGBDBM309329((2R,3aS,4R,9bS)-12-(cyclopropylmethyl)- N-(2-guani...)
Affinity DataEC50: >2.00E+4nMAssay Description:δ-Opioid Receptor Binding Assay Procedures: δ-Opioid Receptor Binding Assay Procedures were conducted as follows. Radioligand dose-displace...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent